CTRI Number |
CTRI/2021/02/031262 [Registered on: 12/02/2021] Trial Registered Prospectively |
Last Modified On: |
18/02/2022 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Ayurveda Other (Specify) [ABDOMINAL BAND] |
Study Design |
Other |
Public Title of Study
|
Abdominal band to reduce central obesity |
Scientific Title of Study
|
An open label double arm control clinical study to evaluate the add on effectiveness of shigruvaadi udara bandhana in central obesity |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
chaithra |
Designation |
PG scholar Department of swasthavritta |
Affiliation |
Sri Dharmasthala Manjunatheswara College of Ayurveda and hospital |
Address |
Department of swasthavritta
Sri Dharmasthala Manjunatheswara College of Ayurveda and hospital,BM Road Thanniruhalla , Hassan,Karnataka 573201 BM Road Thanniruhalla , Hassan,Karnataka 573201 Hassan KARNATAKA 573201 India |
Phone |
9740316888 |
Fax |
|
Email |
hnchaithra12@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Chaithra HN |
Designation |
PG scholar Department of swasthavritta |
Affiliation |
Sri Dharmasthala Manjunatheswara College of Ayurveda and hospital |
Address |
Department of swasthavritta
Sri Dharmasthala Manjunatheswara College of Ayurveda and hospital,BM Road Thanniruhalla , Hassan BM Road Thanniruhalla , Hassan Hassan KARNATAKA 573201 India |
Phone |
9740316888 |
Fax |
|
Email |
hnchaithra12@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Chaithra HN |
Designation |
PG scholar Department of swasthavritta |
Affiliation |
sri Dharmasthala Manjunatheswara College of Ayurveda and hospital |
Address |
Department of swasthavritta
Sri Dharmasthala Manjunatheswara College of Ayurveda and hospital,BM Road Thanniruhalla , Hassan BM Road Thanniruhalla , Hassan Hassan KARNATAKA 573201 India |
Phone |
9740316888 |
Fax |
|
Email |
hnchaithra12@gmail.com |
|
Source of Monetary or Material Support
|
Department of swasthavritta
Sri Dharmasthala Manjunatheswara College of Ayurveda and hospital,BM Road Thanniruhalla , Hassan |
|
Primary Sponsor
|
Name |
Sri Dharmasthala Manjunatheswara College of Ayurveda and hospital |
Address |
Department of swasthavritta
Sri Dharmasthala Manjunatheswara College of Ayurveda and hospital,BM Road Thanniruhalla , Hassan |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Tapas Brata Tripathy |
Sri Dharmasthala Manjunatheswara College of Ayurveda and hospital |
Department of swasthavritta
Sri Dharmasthala Manjunatheswara College of Ayurveda and hospital,BM Road Thanniruhalla , Hassan Hassan KARNATAKA |
9448705599
tbtripathy@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
SRI DHARMASTHALA MANJUNATHESHWARA COLLEGE OF AYURVEDA & HOSPITAL,HASSAN |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:E669||Obesity, unspecified. Ayurveda Condition: MEDOROGAH, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Abdominal band |
Abdominal band 4 hours once in a day external application for 7 days |
Comparator Agent |
NIL |
NIL |
|
Inclusion Criteria
|
Age From |
25.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
2. Waist circumference>40 inches (102 cm) in men and >35 inches (88 cm) in
women.
3. Waist height ratio >0.9 in males and>0.85 in females. |
|
ExclusionCriteria |
Details |
1. Visible wounds over the abdomen and lower back.
2. Pregnant and post-partum woman.
3. Inflammatory skin conditions over the abdomen and lower back.
4. Known case of abnormal abdominal enlargements.
5. Known case of any organomegaly |
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
To reduce central obesity |
Baseline third day seventh day |
|
Secondary Outcome
|
Outcome |
TimePoints |
To reduce bmi |
Baseline third day seventh day |
|
Target Sample Size
|
Total Sample Size="40" Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "44"
Final Enrollment numbers achieved (India)="44" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
20/02/2021 |
Date of Study Completion (India) |
14/01/2022 |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
Modification(s)
|
1. An Open label double armed clinical control study to evaluate the add on effectiveness of shigruvadi udara bhandana in central obesity |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report Response - Analytic Code
- Who will be able to view these files?
Response - Researchers who provide a methodologically sound proposal.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response (Others) -
- For how long will this data be available start date provided 03-03-2022 and end date provided 04-03-2027?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
Brief Summary
|
NAME OF HE DEPARTMENT- DEPARTMENT OF SWASTHAVRITTA NAME OF THE STUDENT-Dr. Chaithra HN NAME OF THE GUIDE- Dr. Tapas Brat Tripathy TITLE OF THE STUDY- “An open label double arm control clinical study to evaluate the add on effectiveness of shigruvaadi udara bandhana in central obesity†SUMMARYObesity is the major health challenge in the present era, mainly caused due to improper way of living and food habits. Central obesity is one of the types of obesity having excess accumulation of fat in the abdominal area with higher health risks. Thus, this study is intended to reduce abdominal obesity using shigruvaadi swedopaga udara bandhana. OBJECTIVESTo evaluate the add on effectiveness of shigruvaadi udara bandhana in central obesity METHODOLOGYMETHODOLOGY-interventional clinical study Research design- An open label double arm control clinical study conducted for 7 days: having 40 participants and 20 participants each are divided among two groups. Group 1(N=20) patients will be given udvartana with udvartana churna- 30 min. Group 2(N=20) patients will be given udvartana with udvartana churna -30 min and udara bandhana-4 hours. Source of data: 40 patients fulfilling the diagnostic criteria and inclusion criteria will be selected from out-patient and in-patient department of swasthavritta and yoga, Sri Dharmasthala college of Ayurveda and hospital. INTERVENTION: For udara bandhana; the drugs -shigru, Yava, tila, Kulatta, masha (drugs mentioned under swedopaga dashemani by Charaka) are made into fine powder, made into lepa and applied over the abdomen about 2 cm thick when it is luke warm in temperature. It is covered by the cotton cloth. Using the other cotton cloth, the abdomen area is tied and left for 4 hours. Later asked to wash with warm water. RESEARCH DESIGNIn the present study 30 patients fulfilling the criteria for inclusion will be selected with convenience sampling technique. The selected patients will be open label single arm interventional study. SAMPLING TECHNIQUE: Convenient sampling method SAMPLE SIZE: 40 participants and 20 participants each are divided among two groups. conducted for 7 days. Diagnostic criteria: • Waist circumference>.40 inches (102 cm) in males and >35 inches (88 cm) in female • Waist height ratio >0.9 in males and>0.85 in females.14 ASSESSMENT CRITERIA Primary assessment: • Waist circumference • Waist height ratio • Abdominal girth • Skin fold thickness Secondary assessment • BMI FOLLOW UP DURING TREATMENT: Patients will be assessed on 3rd and 7th day during the study period. INCLUSION CRITERIA: 1. Age:25-60 yrs. 2. Waist circumference>40 inches (102 cm) in men and >35 inches (88 cm) in women. 3. Waist height ratio >0.9 in males and>0.85 in females. EXCLUSION CRITERIA. 1. Visible wounds over the abdomen and lower back. 2. Pregnant and post-partum woman. 3. Inflammatory skin conditions over the abdomen and lower back. 4. Known case of abnormal abdominal enlargements. 5. Known case of any organomegaly. |